✦ LIBER ✦

A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease

✍ Scribed by Dr. Stanley Fahn

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 396 KB
Volume: 32
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410320722

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of sustained deprenyl (selegiline

Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: A randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial

✍ Ira Shoulson; David Oakes; Stanley Fahn; Anthony Lang; J. William Langston; Pete 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

A phase II trial of high-dose intravenou

A phase II trial of high-dose intravenous interferon alpha-2 in advanced colorectal cancer

✍ Robert M. Silgals; James D. Ahlgren; John R. Neefe; John Rothman; Seth Rudnick; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB 👁 2 views

Predictors and outcomes of scleroderma r

Predictors and outcomes of scleroderma renal crisis: The high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial

✍ Paul J. DeMarco; Michael H. Weisman; James R. Seibold; Daniel E. Furst; Weng Kee 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

High-dose versus low-dose D-penicillamin

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial

✍ Philip J. Clements; Daniel E. Furst; Weng-Kee Wong; Maureen Mayes; Barbara White 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views